Treatment and clinical outcomes of borderline resectable pancreatic cancer of the late elderly

The prognosis of borderline resectable pancreatic cancer in the late elderly compared to another treatment.MST was 10.0 months in the surgery and post-operative adjuvant chemotherapy group, 11.0 months in the group only surgery,10.0 months in the group only chemotherapy and 2 months in the BSC group...

Full description

Saved in:
Bibliographic Details
Published in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2016-08, Vol.16 (4), p.S166-S166
Main Authors: Mashiko, Taro, Masuoka, Yoshihito, Yamada, Misuzu, Izumi, Hideki, Furukawa, Daisuke, Yazawa, Naoki, Nakagohri, Toshio
Format: Article
Language:English
Subjects:
Chemotherapy
Endocrinology & Metabolism
Gastroenterology and Hepatology
Health risk assessment
Pancreatic cancer
Surgery
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The prognosis of borderline resectable pancreatic cancer in the late elderly compared to another treatment.MST was 10.0 months in the surgery and post-operative adjuvant chemotherapy group, 11.0 months in the group only surgery,10.0 months in the group only chemotherapy and 2 months in the BSC group.
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2016.06.597